Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
argenx
ARGX
|
$306M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
$250M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Accel Entertainment
ACEL
$967M
| $227K | ﹤0.01% |
24,935
+13,565
| +119% | +$124K |
|
2427
Artivion
AORT
$2.05B
| $226K | ﹤0.01% |
+17,285
| New | +$226K |
|
2428
Brookdale Senior Living
BKD
$1.83B
| $226K | ﹤0.01% |
76,588
+39,350
| +106% | +$116K |
|
2429
Diamond Hill
DHIL
$388M
| $224K | ﹤0.01% |
+1,367
| New | +$224K |
|
2430
Calavo Growers
CVGW
$485M
| $224K | ﹤0.01% |
+7,788
| New | +$224K |
|
2431
Life Time Group Holdings
LTH
$6.38B
| $224K | ﹤0.01% |
+14,013
| New | +$224K |
|
2432
Stoneridge
SRI
$226M
| $223K | ﹤0.01% |
+11,948
| New | +$223K |
|
2433
Grab Holdings Limited Warrant
GRABW
$9.88M
| $222K | ﹤0.01% |
403,754
-182
| -0% | -$100 |
|
2434
Arlo Technologies
ARLO
$1.89B
| $222K | ﹤0.01% |
36,727
+20,223
| +123% | +$122K |
|
2435
Acco Brands
ACCO
$364M
| $222K | ﹤0.01% |
41,722
+22,530
| +117% | +$120K |
|
2436
Byline Bancorp
BY
$1.33B
| $222K | ﹤0.01% |
+10,263
| New | +$222K |
|
2437
Editas Medicine
EDIT
$248M
| $222K | ﹤0.01% |
30,548
+16,857
| +123% | +$122K |
|
2438
Central Pacific Financial
CPF
$841M
| $222K | ﹤0.01% |
+12,373
| New | +$222K |
|
2439
SmartFinancial
SMBK
$631M
| $221K | ﹤0.01% |
+9,545
| New | +$221K |
|
2440
Genesco
GCO
$360M
| $220K | ﹤0.01% |
+5,982
| New | +$220K |
|
|
VERV
2441
DELISTED
Verve Therapeutics
VERV
| $220K | ﹤0.01% |
+15,286
| New | +$220K |
|
2442
E.W. Scripps
SSP
$261M
| $220K | ﹤0.01% |
23,396
+12,738
| +120% | +$120K |
|
2443
Vaalco Energy
EGY
$399M
| $220K | ﹤0.01% |
48,539
+4,340
| +10% | +$19.6K |
|
|
CLDT
2444
Chatham Lodging
CLDT
$363M
| $218K | ﹤0.01% |
+20,799
| New | +$218K |
|
|
FPI
2445
Farmland Partners
FPI
$473M
| $218K | ﹤0.01% |
+20,329
| New | +$218K |
|
2446
Universal Insurance Holdings
UVE
$697M
| $218K | ﹤0.01% |
+11,948
| New | +$218K |
|
2447
European Wax Center
EWCZ
$180M
| $217K | ﹤0.01% |
+11,403
| New | +$217K |
|
2448
CareDx
CDNA
$736M
| $217K | ﹤0.01% |
23,680
+13,149
| +125% | +$120K |
|
2449
Vanguard Growth ETF
VUG
$186B
| $216K | ﹤0.01% |
866
-619
| -42% | -$154K |
|
2450
Franklin Covey
FC
$244M
| $216K | ﹤0.01% |
+5,610
| New | +$216K |
|